Breast cancer treatment with imiquimod: applying an old lotion to a new disease.
review · Level V
Where this comes from
- Record sourced from PubMed, PMID 23172886.
- Also identified by DOI 10.1158/1078-0432.CCR-12-3138.
- No licence information is recorded for this record.
- Because redistribution is not established, this page shows the abstract only. Follow the links below for the full text.
Abstract
Over the prior two decades, imiquimod, a toll-like receptor 7 agonist, has been applied to nearly 50 clinical settings. Because of its immunomodulatory role, the topical cream today, for the first time, is being applied to cutaneous breast cancer in preclinical models and in a phase II clinical trial.
Medical subject headings
- Aminoquinolines
- Antineoplastic Agents
- Antineoplastic Combined Chemotherapy Protocols
- Breast Neoplasms
- Carcinoma, Ductal, Breast
- Mammary Neoplasms, Experimental
- Membrane Glycoproteins
- Skin Neoplasms
- Toll-Like Receptor 7